Acro Biomedical Co Ltd   (ACBM)
Other Ticker:  
    Sector  Services    Industry Hotels & Tourism
   Industry Hotels & Tourism
   Sector  Services


Acro Biomedical Co Ltd

ACBM's Financial Statements and Analysis

Acro Biomedical Co Ltd reported break-eaven for the III. Quarter compare to net loss per share of $-0.05 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ 0 $  0 Mill
$+0.05     Unch.    

Acro Biomedical Co Ltd 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.

Acro Biomedical Co Ltd is Expected to report next financial results on April 14, 2023.

More on ACBM's Income Statement

Acro Biomedical Co Ltd 's in III. Quarter recorded net loss of $-4.011 million, an increase from net loss of $-2.991 million in III. Quarter a year ago.

Sequentially net loss advanced

More on ACBM's Growth

Inventories declined by -33.93 % to $0.30 million from III. Quarter a year ago, sequentially inventories fell by 0 %. ACBM's Cash flow In III. Quarter company's net cash flow was $0 million

Acro Biomedical Co Ltd does not pay out common stock dividend.

In trailing twelve-month period Acro Biomedical Co Ltd payed $ 0.00 cash per share, on a free-cash flow basis .